Full Text
The Full Text of this article is available as a PDF (1.0 MB).
Contributor Information
Shalini L. Kulasingam, Center for Clinical Health Policy Research, Duke Evidence-Based Practice Center, and Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
Gregory P. Samsa, Center for Clinical Health Policy Research, Duke Evidence-Based Practice Center, and Department of Medicine, Duke University Medical Center, Durham, North Carolina.
David B. Matchar, Center for Clinical Health Policy Research, Duke Evidence-Based Practice Center, Department of Community and Family Medicine, Duke University Medical Center, and Department of Veterans Affairs Medical Center, Durham, North Carolina.
References
- 1. NCA Tracking Sheet for Positron Emission Tomography (FDG) and Other Neuroimaging Devices for Suspected Dementia (CAG- 00088R). Available online at: https://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=104.
- 2. Matchar DM, Kulasingam SL, McCrory DC, et al.: Use of positron emission tomography and other neuroimaging techniques in the diagnosis and management of Alzheimer's disease and dementia: Task Order No. 7. Prepared by Duke University under Contract No. 290-97-0014. Rockville, MD: Agency for Health Care Policy and Research, February 2002. Available online at: http.:www.cms.hhs.gov/coveragedownload/id64.pdf. [Google Scholar]
- 3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC; American Psychiatric Association, 1994. [Google Scholar]
- 4. Small GW, Rabins PV, Barry PP, et al.: Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association and the American Geriatrics Society. JAMA. 1997; 278: 1363-1371. [PubMed] [Google Scholar]
- 5. McKhann G. Drachman D, Folstein M, et al.: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984; 34: 939-944. [DOI] [PubMed] [Google Scholar]
- 6. Knopman DS, DeKosky ST, Cummings JL, et al.: Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56: 1143-1153. [DOI] [PubMed] [Google Scholar]
- 7. Hoffman JM, Welsh-Bohmer KA, Hanson M, et al.: FDG PET imaging in patients with pathologically verified dementia. J Nucl Med. 2000; 41: 1920-1928. [PubMed] [Google Scholar]
- 8. Bookheimer SY, Strojwas MH, Cohen MS, et al.: Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000; 343: 450-456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Silverman DH, Small GW, Chang CY, et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA. 2001; 286: 2120-2127. [DOI] [PubMed] [Google Scholar]
- 10. Small GW, Ercoli LM, Silverman DH, et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA. 2000; 97: 6037-6042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Kulasingam SL, Samsa GP, Zarin DA, et al. When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision-analysis. Value Health. 2003; 6: 542-550. [DOI] [PubMed] [Google Scholar]
- 12. Doody RS, Stevens JC, Beck C, et al.: Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56: 1154-1166. [DOI] [PubMed] [Google Scholar]
- 13. Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003; 290: 1624-1632. [DOI] [PubMed] [Google Scholar]